Dr. McDonald is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Department of Physical Medicine Rehabilitation
4860 Y Street, Suite 3850
Sacramento, CA 95817Phone+1 916-734-2923Fax+1 916-734-7838
Summary
- Craig McDonald, M.D. is a Professor of Pediatrics and Physical Medicine and Rehabilitation, and Chair of the Department of Physical Medicine & Rehabilitation at University of California Davis. He is an internationally recognized expert in the clinical management, rehabilitation, and precision therapeutics for children and adults with muscle diseases. He has been a pioneer in the development of novel outcome measures for clinical trials in disabled populations. He is widely known for his expertise in the treatment and evaluation of children and young adults with Duchenne muscular dystrophy (DMD). He leads the Cooperative International Neuromuscular Research Group (CINRG) Duchenne Natural History Study, a collaborative effort which has made seminal contributions to the elucidation of the natural history of DMD and validation of the clinical endpoints now used in clinical trials of DMD throughout the world. Recently he led the first cell therapy trial in DMD and has he has helped design international multicenter gene therapy trials for muscular dystrophies.
Education & Training
- University of Washington/Seattle Children's HospitalChief Residency, Pediatric Physical Medicine & Rehabilitation, 1991 - 1992
- University of WashingtonResidency, Physical Medicine and Rehabilitation, 1989 - 1992
- University of Washington Graduate SchoolMaster's, Rehabilitation Medicine, 1989 - 1991
- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Pediatrics, 1988 - 1989
- University of Washington School of MedicineClass of 1987
- Stanford UniversityA.B., Human Biology, with Thesis Honors and Distinction, 1978 - 1982
Certifications & Licensure
- CA State Medical License 1988 - 2025
- American Board of Physical Medicine and Rehabilitation Physical Medicine & Rehabilitation
- American Board of Physical Medicine and Rehabilitation Neuromuscular Medicine
- American Board of Physical Medicine and Rehabilitation Pediatric Rehabilitation Medicine
Awards, Honors, & Recognition
- 2023 Top 10 Clinical Research Achievement Award nationally Clinical Research Forum, 2023
- UC Davis Hibbard Williams Extraordinary Achievement Award in Recognition of Lifetime Commitment and Service to the School of Medicine. UC Davis School of Medicine, 2023
- Castle Connolly Top Doctor Castle Connolly Medical Ltd., 2015-2023
- Join now to see all
Publications & Presentations
PubMed
- Caregiver Global Impression Observations from EMBARK: A Phase 3 Study Evaluating Delandistrogene Moxeparvovec in Ambulatory Patients with Duchenne Muscular Dystrophy.Craig M McDonald, Jacob S Elkins, Sai Dharmarajan, Katherine Gooch, Teofil Ciobanu
Neurology and Therapy. 2025-02-01 - 7 citationsAAV gene therapy for Duchenne muscular dystrophy: the EMBARK phase 3 randomized trial.Jerry R Mendell, Francesco Muntoni, Craig M McDonald, Eugenio M Mercuri, Emma Ciafaloni
Nature Medicine. 2025-01-01 - 3 citationsSurvival among patients receiving eteplirsen for up to 8 years for the treatment of Duchenne muscular dystrophy and contextualization with natural history controls.Joel Iff, Nicolae Done, Edward Tuttle, Yi Zhong, Fangzhou Wei
Muscle & Nerve. 2024-07-01
Press Mentions
- Boys with DMD Given Elevidys Two Years Ago Still Showing Motor GainsJanuary 28th, 2025
- UC Davis Health Releases DocumentaryDecember 19th, 2024
- Sevasemten Lowers Markers of Muscle Damage in BMD: TrialDecember 17th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: